Table 3.
Bioactive Components of Natural Medicine That Can Promote HIF-1α
| Compounds | Original Plants | Chemical Structure | Models | Mechanism | Disease | Refs. | 
|---|---|---|---|---|---|---|
| Glycosides | ||||||
| Astragaloside IV | Astragalus propinquus Schischkin | ![]()  | 
HUVECs | Promoting cell proliferation and stimulated HIF-1α accumulation by PI3K/Akt pathway, not affecting the degradation of HIF-1α protein or the level of HIF-1α mRNA, inducing the nuclear translocation of HIF-1α. | Myocardial ischemia | [171] | 
| Notoginsenoside R1 | Panax notoginseng (Burk.) F.H.Chen | ![]()  | 
Male SD rats (200 ± 20 g) with cisplatin | Reducing the levels of ROS, MDA and NO, as well as the opening of MPTP, increasing the levels of HIF-1α mRNA, SOD, CAT and GSH, as well as ATP and MMP in renal tissues. | Mitochondrial damage induced by cisplatin | [172] | 
| Salidroside | Rhodiola rosea L. | ![]()  | 
Neonatal rat cardiomyocyte | Up-regulating the HIF-1α and VEGF protein expression, inducing HIF-1α translocation; | Heart failure | [173] | 
| HEK293T, HepG2 cells | Inducing the expression of EPO mRNA from its transcription regulatory HRE, stimulating the accumulation of HIF-1α by inhibiting HIF-1α degradation | Mountain sickness | [89,117] | |||
| ROB, MG-63 cells | Stimulating osteoblast differentiation and mineralization by inducing the expression of Runx2 and Osterix, up-regulating HIF-1α expression at the mRNA and protein levels via MAPK/ERK and PI3K/Akt signaling.  | 
Fracture | [118] | |||
| Polysaccharides | ||||||
| Rhamnose, xylose, mannose, galactose, glucose | Enteromorpha Prolifera | 
![]() ![]() ![]()  
 | 
HCMVEC; | Protecting HCMVEC from OGD-induced viability loss, proliferation inhibition, apoptosis, inflammatory cytokine expression, and autophagy, enhancing the expression of HIF-1α in HCMVEC via the MEK/ERK pathway, attenuating OGD-induced NF-κB pathway activation and promoted the mTOR pathway in HCMVEC; | Acute myocardial infarction | [174] | 
| Wistar rats pre-treated by PEP | Reducing the infarct size and enhancing the LVEDD, LVEF and LVFS of rats via up-regulation of HIF-1α. | Acute myocardial infarction | [174] | |||
| Quinones | ||||||
| Tanshinone IIA | Salvia miltiorrhiza Bge. | ![]()  | 
Male SD rats weighing 200- | Improving heart function, reducing infarct size, and increasing survival rate, up-regulating the expression of HIF-1α and VEGF. | Myocardial ischemia | [120] | 
| 220 g (aged 10 weeks) with myocardial infarction | Improving heart function, reducing infarct size, and increasing survival rate, up-regulating the expression of HIF-1α and VEGF. | Myocardial ischemia | [120] | |||






